{"database": "openregs", "table": "cfr_sections", "rows": [["21:21:6.0.1.1.11.0.1.118", 21, "Food and Drugs", "I", "E", "520", "PART 520\u2014ORAL DOSAGE FORM NEW ANIMAL DRUGS", "", "", "520.1084", "\u00a7 520.1084 Grapiprant.", "FDA", "21 U.S.C. 360b.", "40 FR 13838, Mar. 27, 1975, unless otherwise noted.", "[81 FR 36789, June 8, 2016, as amended at 83 FR 14587, Apr. 5, 2018]", "(a)  Specifications.  Each tablet contains 20, 60, or 100 milligrams (mg) grapiprant.\n\n(b)  Sponsor.  See No. 058198 in \u00a7 510.600(c) of this chapter.\n\n(c)  Conditions of use in dogs \u2014(1)  Amount.  Administer 0.9 mg/lb (2 mg/kg) once daily by mouth.\n\n(2)  Indications for use.  For the control of pain and inflammation associated with osteoarthritis in dogs.\n\n(3)  Limitations.  Federal law restricts this drug to use by or on the order of a licensed veterinarian."]], "columns": ["section_id", "title_number", "title_name", "chapter", "subchapter", "part_number", "part_name", "subpart", "subpart_name", "section_number", "section_heading", "agency", "authority", "source_citation", "amendment_citations", "full_text"], "primary_keys": ["section_id"], "primary_key_values": ["21:21:6.0.1.1.11.0.1.118"], "units": {}, "query_ms": 0.2699950127862394, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}